首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Comparison of the haemodynamic effects of adenosine monophosphate with sodium nitroprusside in a canine model of acute global left ventricular dysfunction.
【2h】

Comparison of the haemodynamic effects of adenosine monophosphate with sodium nitroprusside in a canine model of acute global left ventricular dysfunction.

机译:在急性全球性左心功能不全犬模型中单磷酸腺苷和硝普钠的血液动力学效应比较。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. The haemodynamic effects of adenosine 5'-monophosphate (AMP) and sodium nitroprusside (SNP) were compared in anaesthetized dogs following the induction of acute left ventricular (LV) dysfunction. 2. LV dysfunction was induced by the intracoronary administration of glass microbeads until left ventricular end diastolic pressure (LVEDP) was increased from 5 to 15 mmHg. This was associated with a decrease in LV dP/dt and cardiac index (CI) of 30% and 27%, respectively, and an increase in systemic vascular resistance index (SVRI) of 37%. 3. Graded doses of AMP (100 to 1000 micrograms kg-1 min-1) or SNP (1 to 10 micrograms kg-1 min-1) reduced SVRI and increased CI in a dose-related manner. Heart rate was not altered by either agent. At doses that caused similar reductions in SVRI, CI was increased more by AMP than by SNP. 4. The mechanisms responsible for the greater elevation of CI by AMP relative to SNP may be related to its more selective arterial vasodilator activity. SNP reduced cardiac preload that limited the expected increase in CI. 5. The haemodynamic profile of AMP suggests that it may be useful in the pharmacological management of acute cardiac failure, either when used alone or in combination with positive inotropic agents and/or selective venodilators.
机译:1.比较了诱发急性左心功能不全的麻醉犬中5'-单磷酸腺苷(AMP)和硝普钠(SNP)的血流动力学效应。 2.冠状动脉内施用玻璃微珠可诱发LV功能障碍,直至左心室舒张末期压力(LVEDP)从5 mmHg增加至15 mmHg。这与LV dP / dt和心脏指数(CI)分别降低30%和27%,以及全身血管阻力指数(SVRI)升高37%有关。 3. AMP(100至1000微克kg-1 min-1)或SNP(1至10微克kg-1 min-1)的分级剂量以剂量相关的方式降低了SVRI,并增加了CI。两种药物均未改变心率。在引起SVRI相似降低的剂量下,AMP引起的CI升高大于SNP引起的CI升高。 4. AMP相对于SNP导致CI升高的机制可能与其选择性的血管舒张活性有关。 SNP降低了心脏预负荷,从而限制了预期的CI升高。 5. AMP的血流动力学特征表明,当单独使用或与正性肌力药和/或选择性通心扩张剂联合使用时,AMP在急性心力衰竭的药理管理中可能有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号